共 56 条
p300/MDM2 complexes participate in MDM2-mediated p53 degradation
被引:363
作者:
Grossman, SR
Perez, M
Kung, AL
Joseph, M
Mansur, C
Xiao, ZX
Kumar, S
Howley, PM
Livingston, DM
机构:
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[4] Tufts Univ, Sch Med, Boston, MA 02111 USA
[5] New England Med Ctr, Dept Dermatol, Boston, MA 02111 USA
[6] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
[7] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
关键词:
D O I:
10.1016/S1097-2765(00)80140-9
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Control of p53 turnover is critical to p53 function. E1A binding to p300/CBP translates into enhanced p53 stability, implying that these coactivator proteins normally operate in p53 turnover control. In this regard, the p300 C/H1 region serves as a specific in vivo binding site for both p53 and MDM2, a naturally occurring p53 destabilizer. Moreover, most of the endogenous MDM2 is bound to p300, and genetic analysis implies that specific interactions of p53 and MDM2 with p300 C/H1 are important steps in the MDM2-directed turnover of p53. A specific role for p300 in endogenous p53 degradation is underscored by the p53-stabilizing effect of overproducing the p300 C/H1 domain. Taken together, the data indicate that specific interactions between p300/CBP C/H1, p53, and MDM2 are intimately involved in the MDM2-mediated control of p53 abundance.
引用
收藏
页码:405 / 415
页数:11
相关论文